Suppr超能文献

[VIVA尿道塞:用于压力性尿失禁保守治疗的合理范围扩展?]

[The VIVA urethral plug: a sensible expansion of the spectrum for conservative therapy of urinary stress incontinence?].

作者信息

Peschers U, Zen Ruffinen F, Schaer G N, Schüssler B

机构信息

Frauenklinik, Kantonsspital Luzern.

出版信息

Geburtshilfe Frauenheilkd. 1996 Mar;56(3):118-23. doi: 10.1055/s-2007-1022276.

Abstract

OBJECTIVE

To evaluate applicability, acceptance, side effects and complications and the possible curative effect on female stress urinary incontinence of the treatment with the urethral plug VIVA (Braun Melsungen, Germany).

DESIGN

Part I: Prospective clinical study. Part II: Ongoing prospective-longitudinal study. Additionally two case reports.

SUBJECTS

Part II: 156 consecutive patients of the urodynamic out patient clinic. Part II: 21 patients with urinary stress incontinence (SUI).

MAIN OUTCOME MEASURES

Part I: Ability to hold the plug while walking and standing, acceptance rate of plug therapy. Part II: Subjective improvement of SUI, pad-weighing test, cough test, urinary tract infections, other complications during four months of plug treatment.

RESULTS

Part I: 62% of 156 patients were able to hold the plug. 40% of 53 patients with SUI accepted the plug treatment. Part II: 14 patients completed the study. 4 pat. were subjectively and objectively cured, 3 were improved, 7 unchanged. The cured patients all had a low grade SUI with a urine loss of 3 g in the pad-weighing test before treatment. 12/21 pat, showed 1-2 urinary tract infections and 1 patient dropped out from the study because of recurrent urinary tract infections. In one patient a plug migrated into the bladder and was removed cystoscopically. In two case reports the possibility of symptomatic plug treatment for patients with severe stress incontinence after surgical and radiological treatment of cervical cancer is demonstrated.

CONCLUSIONS

Plug treatment is a broadening of the spectrum of conservative treatment of SUI as a symptomatic treatment in pat. with contraindications to anti-incontinence surgery and as a curative treatment in low grade SUI.

摘要

目的

评估尿道塞VIVA(德国布劳恩梅尔松根公司生产)治疗女性压力性尿失禁的适用性、可接受性、副作用、并发症以及可能的疗效。

设计

第一部分:前瞻性临床研究。第二部分:正在进行的前瞻性纵向研究。另外还有两个病例报告。

研究对象

第二部分:尿动力学门诊的156例连续患者。第二部分:21例压力性尿失禁(SUI)患者。

主要观察指标

第一部分:行走和站立时保持尿道塞的能力、尿道塞治疗的接受率。第二部分:压力性尿失禁的主观改善情况、护垫称重试验、咳嗽试验、尿路感染、尿道塞治疗四个月期间的其他并发症。

结果

第一部分:156例患者中有62%能够保持尿道塞。53例压力性尿失禁患者中有40%接受了尿道塞治疗。第二部分:14例患者完成了研究。4例患者主观和客观上均治愈,3例改善,7例无变化。治愈的患者均为轻度压力性尿失禁,治疗前护垫称重试验中尿失禁量为3克。21例患者中有12例出现1 - 2次尿路感染,1例患者因反复尿路感染退出研究。1例患者的尿道塞移入膀胱,通过膀胱镜检查取出。在两个病例报告中,展示了对宫颈癌手术和放射治疗后严重压力性尿失禁患者进行症状性尿道塞治疗的可能性。

结论

尿道塞治疗拓宽了压力性尿失禁保守治疗的范围,可作为有抗尿失禁手术禁忌证患者的症状性治疗方法,以及轻度压力性尿失禁的治愈性治疗方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验